- Thou shalt read these 11 Twitter commandments of Corporate Tweeting, http://ow.ly/1fLGS #
- Roche and Biogen halt development of ocrelizumab, http://ow.ly/1ghYn #
- Missouri's biotech push might bolster state economy, governor says, http://ow.ly/1ghZd #
- FDA approves facility for production of Cell Therapeutics' pixantrone, http://ow.ly/1gi0r #
- Acetylon is in deal with Harvard, Dana-Farber for HDAC inhibitors, http://ow.ly/1gi1r #
- ImmunoGen treatment receives orphan-drug status in U.S., Europe, http://ow.ly/1gi1Y #
- If capital is your top concern, rethink your priorities, http://ow.ly/1giQo #
- Lassen launches “turnkey technology marketing department”, http://ow.ly/1gjIe #
- Money – Loonie at par by summer: CIBC, http://ow.ly/1gAi0 #
- It's confirmed: For the project in Leuven (Belgium), leaving on the 19th of April and coming back on the 3rd of November (all in 2010). #
- RT @NeowinFeed: Windows Phone Series 7 gaming shown off (screenshots) http://neow.in/dAzGj3 #
- Yissum introduces system to track, analyze human spatial behavior, http://ow.ly/1eMl5 #
- Good customer relations requires more than friends and tweets, http://ow.ly/1eMty #
- Innate Pharma will focus R&D on monoclonal antibodies, http://ow.ly/1fLtG #
- AIDS virus hides and stays dormant in bone marrow, study says, http://ow.ly/1fLA7 #
- Researchers discover a form of prion disease in bioengineered mice, http://ow.ly/1fLB0 #
- 3 organizations will explore genes for clues to breast cancer, http://ow.ly/1fLCh #
- Aveo Pharmaceuticals will go public with 7 million shares, http://ow.ly/1fLDn #
- XenoPort plans to cut jobs, concentrate on late-stage drug candidates, http://ow.ly/1fLEG #
- Humanetics seeking funding to develop anti-radiation drug, http://ow.ly/1fLFA #
- Time to go sit on a panel discussion at the McGill Grad Career Month #
- Full Circle Investments plans $30M fund, http://ow.ly/1eMhh #
- OSI shareholder tells Astellas to increase takeover bid by 15%, http://ow.ly/1eM9w #
- Study identifies two types of self-renewing blood cells, http://ow.ly/1eMaW #
- Study: Vaccine triggers immune response against mesothelioma, http://ow.ly/1eMbI #
- Bristol-Myers details strategy to offset future Plavix losses, http://ow.ly/1eMcg #
- FDA approves immune-replacement drug Hizentra, http://ow.ly/1eMd2 #
- BioVex begins Phase I trial of genital herpes vaccine in U.K., http://ow.ly/1eMea #
- Dow AgroSciences to spend $340M on research expansion in Indianapolis, http://ow.ly/1eMfG #
- Arizona Technology Enterprises partners with Japan Technology Group, http://ow.ly/1eMib #
- Purdue Research Foundation establishes network for angel investors, http://ow.ly/1eMjU #
- RT @biotechmontreal: Semaine prochaine / Next week: 2010-03-16 – LAB – RSVP: http://ow.ly/1fLoW #
- RT @ogilvyrenault: Toronto and Tel Aviv Exchanges Sign MoU: Is Dual-Listing on the Horizon? http://bit.ly/dmfkmJ #
- RT @ogilvyrenault: Canada federal budget 2010: Changes in tax law favourable to international investors http://bit.ly/bnqcKi #
- RT @NeowinFeed: Steam coming to OS X in April; no repurchasing required http://neow.in/acM5Ub #
- Great leaders don't need to hide their flaws, http://ow.ly/1dRWF #
- Study: Stomach hormone holds promise for liver fibrosis, http://ow.ly/1dROL #
- Sea squirt might help find drugs for Alzheimer's disease, http://ow.ly/1dRPv #
- Prostate cancer vaccine Provenge won't undergo FDA panel review, http://ow.ly/1dRRJ #
- Company announces feat on special stem cells, http://ow.ly/1dRSW #
- Inovio unit gets approval in South Korea to test avian flu vaccine, http://ow.ly/1dRU3 #
- Why vision matters more than ideas, http://ow.ly/1dRYJ #
- Don't hit snooze — hit reset: Clean Slates, http://ow.ly/1dS09 #
- RT @ogilvyrenault: A New Breed of Patent Troll? False Patent Marking in the US http://bit.ly/9cwJHH #
- Leuven project update: Official Carte Pro approval getting closer (which means I should get the all-clear for the visa soon). #
- RT @TheEconomist: Lessons for lottery winners http://econ.st/ataSk2 #economist #
- RT @UrbanDaddy: Taking the mechanical bull by the horns. http://sflow.us/d75VPG #Vegas #
- RT @TheEconomist: New column: Few companies are ready to accept cloud computing: http://econ.st/9LTV6c #economist #
- Chi-Med seeks partner for stomach drug, http://ow.ly/1eMdG #
- It's Friday, Time for beer! #
- Data-driven intelligence helps businesses thrive, http://ow.ly/1dRVZ #
- New vaccine could slow Parkinson's disease progression in humans, http://ow.ly/1dhVH #
- Celsion will begin Phase II trial of ThermoDox later this year, http://ow.ly/1dhYV #
- Ariad's blood cancer drug gains FDA orphan-drug status, http://ow.ly/1di0U #
- Farmers seek injunction on use of biotech sugar beets, http://ow.ly/1di68 #
- Google sparks new wave of innovation, http://ow.ly/1di8R #
- Face-to-face marketing matters more than ever, http://ow.ly/1dqpK #
- Stem Cell Innovations obtains research contract from German firm Agennix, http://ow.ly/1dRND #
- Synta gets FDA clearance to resume work on skin cancer drug, http://ow.ly/1dRQa #
- RT @davidgerzof: How much are social media platforms worth? FB $11.5B, Twitter $1.4B, LinkedIn $1.3B, 2nd Life $383M, http://bit.ly/bVil57 #
- Merck KGaA plans to move U.S. chemical unit to Massachusetts, http://ow.ly/1ekFb #
- Stemgent invests $4.5M in Scotland-based startup firm, http://ow.ly/1el1V #
- Report: Iceland is more creative than America, http://ow.ly/1embS #
